Thalys Medical Technology Group Corporation (SHA:603716)
China · Delayed Price · Currency is CNY 15.95
-0.29 (-1.79%)
Jun 8, 2026, 3:00 PM CST
SHA:603716 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -210.48 | -207.28 | -209.24 | -158.57 | -153.73 | -49.51 |
Depreciation & Amortization | 42.51 | 42.51 | 52.72 | 74.71 | 84.35 | 96.28 |
Other Amortization | 8.8 | 8.8 | 9.86 | 9.7 | 23.22 | 19.58 |
Loss (Gain) From Sale of Assets | 0.25 | 0.25 | -7.62 | 2.54 | 0.02 | -0.4 |
Asset Writedown & Restructuring Costs | 55.03 | 55.03 | 24.18 | 35.91 | 19.18 | 0.72 |
Loss (Gain) From Sale of Investments | -2.22 | -2.22 | 68.01 | 11.3 | 31.8 | 25.66 |
Provision & Write-off of Bad Debts | -10.24 | -10.24 | -38.53 | 28.17 | 91.54 | 62.11 |
Other Operating Activities | 79.93 | 40.51 | 77.83 | 129.87 | 64.36 | 110.78 |
Change in Accounts Receivable | -32.03 | -32.03 | 65.62 | 5.19 | -171.05 | -457.83 |
Change in Inventory | 102.78 | 102.78 | 15.44 | 79.15 | 42.89 | -61.16 |
Change in Accounts Payable | -74.18 | -74.18 | 11.43 | -16.88 | 39.91 | 151.89 |
Change in Other Net Operating Assets | - | - | - | - | -4.58 | -2.64 |
Operating Cash Flow | -1.52 | -37.75 | 99.6 | 125.89 | 28.12 | -133.52 |
Operating Cash Flow Growth | - | - | -20.89% | 347.65% | - | - |
Capital Expenditures | -5.13 | -5.72 | -23.21 | -40.83 | -54.64 | -60.19 |
Sale of Property, Plant & Equipment | 0.21 | 0.13 | 0.54 | 0.31 | 0.24 | 14.44 |
Divestitures | -10.58 | 24.66 | 27.49 | -4.94 | -16.73 | 2.65 |
Investment in Securities | -3.08 | 11.14 | -12.49 | 49.12 | 121.62 | -77.63 |
Other Investing Activities | -5.78 | 0 | 0 | 11.52 | 109.22 | 6 |
Investing Cash Flow | -24.36 | 30.21 | -7.67 | 15.19 | 159.71 | -114.72 |
Long-Term Debt Issued | - | 387.81 | 443.05 | 892.36 | 1,235 | 1,112 |
Long-Term Debt Repaid | - | -409.36 | -516.38 | -1,075 | -1,494 | -962.8 |
Net Debt Issued (Repaid) | 24.33 | -21.56 | -73.33 | -182.17 | -259.4 | 149.39 |
Issuance of Common Stock | - | - | - | - | 1.59 | - |
Repurchase of Common Stock | - | - | -29.72 | - | - | -50.27 |
Common Dividends Paid | -18.06 | -18.56 | -31.69 | -38.8 | -52.25 | -49.52 |
Other Financing Activities | -18.68 | -37.73 | -13.52 | 6.66 | -6.58 | 11.78 |
Financing Cash Flow | -12.41 | -77.84 | -148.27 | -214.31 | -316.64 | 61.39 |
Foreign Exchange Rate Adjustments | 0.01 | -0 | 0 | -0.04 | 0.03 | -0.03 |
Net Cash Flow | -38.28 | -85.38 | -56.35 | -73.26 | -128.78 | -186.88 |
Free Cash Flow | -6.66 | -43.47 | 76.39 | 85.06 | -26.52 | -193.71 |
Free Cash Flow Growth | - | - | -10.20% | - | - | - |
Free Cash Flow Margin | -0.69% | -4.04% | 4.22% | 4.24% | -1.15% | -7.45% |
Free Cash Flow Per Share | -0.03 | -0.22 | 0.40 | 0.44 | -0.14 | -0.98 |
Cash Income Tax Paid | 66.53 | 76.66 | 96.78 | 110.37 | 150.82 | 139.56 |
Levered Free Cash Flow | 238.06 | 268.82 | 228.45 | 375.96 | 236.34 | -184.22 |
Unlevered Free Cash Flow | 260.65 | 289.78 | 264.5 | 423.58 | 298.07 | -132.49 |
Change in Working Capital | 34.91 | 34.91 | 122.38 | -7.73 | -132.63 | -398.76 |